Join to access to all OVN content. Join for Free
No “D”…No Problem: Finding Success WITHOUT a Doctorate
Medical Science Liaison MSL career paths personal branding in medical affairs networking in pharmaceutical industry non-doctorate MSL roles

No “D”…No Problem: Finding Success WITHOUT a Doctorate


Share This Article


Summary

In this episode, Greg Auclair from Cytokinetics shares his journey into medical affairs and insights into the MSL role. He discusses his transition, the evolving career paths for MSLs, and the importance of personal branding and networking. Greg offers valuable advice for aspiring MSLs, emphasizing persistence and the creation of a personal development plan. He also highlights non-doctorate paths into the field and addresses changing hiring trends. The episode concludes with Greg reflecting on his career highlights and expressing gratitude, followed by a call to action for listeners to subscribe and provide feedback.

Key Points

  • Networking and gaining experience through contract MSL roles can be crucial for breaking into medical affairs without a doctorate. Demonstrating a deep knowledge of your company's data, competitors' data, and therapeutic space is essential for establishing credibility with key opinion leaders. Developing an individual development plan with your manager and showing polite persistence can help those looking to advance or transition in their careers.

This episode is sponsored by MSL Mastery, helping Medical Science Liaisons and aspiring MSLs to excel in their careers and lives through courses, coaching, and community. For more details, please visit MSLmastery.com.

The MSL Talk Podcast is available on all podcast platforms and the MSL Talk YouTube Channel.

MSL Talk is a podcast that features helpful information for current Medical Science Liaisons, Medical Affairs leaders, job seekers looking to break into the pharmaceutical industry in their first MSL role as well as anyone interested in hearing good industry conversations and medical affairs discussions.

Click for Source
Medical Science Liaison, MSL career paths, personal branding in medical affairs, networking in pharmaceutical industry, non-doctorate MSL roles

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
OVN Avatar S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny

Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale

Article
Sponsorship of oncology clinical trials in the United States according to age of eligibility
OVN Avatar Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois

Sponsorship of oncology clinical trials in the United States according to age of eligibility

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts Kågedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Article
Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?
OVN Avatar Karen Geary

Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

Explore OVN